Aspirin resistance in children and young adults with splenectomized thalassemia diseases

Thrombosis Research
Nongnuch SirachainanAnucha Soisamrong

Abstract

Aspirin is now recommended for splenectomized thalassemia patients with high platelet counts. However, aspirin resistance defined by arachinodic acid (ACA) induced platelet aggregation ≥20%, has never been reported in this group of patients. In this study, twenty-four splenectomized thalassemia patients (15.7±4.1years), with platelet counts ≥800x10(9)/L, and 21 non-splenectomized severe thalassemia patients (14.3±3.2years), were enrolled. After taking aspirin (2mg/kg/day), seven patients (29.2%) displayed aspirin resistance. Serum thromboxane B2 (TXB2) levels in the aspirin responsive group decreased significantly [52.6(8.8-174.6) vs 4.0(1.6-7.3) mcg/mL, p<0.001], while no change was demonstrated in the aspirin resistant group. Having increased aspirin to 4mg/kg/day, three of the seven aspirin resistant patients responded, while one developed upper GI bleeding from esophageal varices and was withdrawn from the study. For the three remaining patients, their doses were increased to the maximum of 300mg/day, and two of the three responded. Thrombin antithrombin complex and D-dimer levels were significantly decreased after taking aspirin (2mg/kg/day), although D-dimer level was still significantly higher than that in non-splenectom...Continue Reading

References

Jun 1, 1977·Archives of Disease in Childhood·B Modell
Jul 1, 1980·The Journal of Pediatrics·A CohenE Schwartz
Jul 21, 1998·Annals of the New York Academy of Sciences·S FucharoenP Pootrakul
Dec 21, 2000·British Journal of Haematology·M D CappelliniA P Mannucci
May 29, 2002·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·R E RollerE Pilger
Jan 2, 2003·Nature Reviews. Drug Discovery·Deepak L Bhatt, Eric J Topol
Feb 18, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·John W Eikelboom, Graeme J Hankey
Feb 28, 2004·BMJ : British Medical Journal·Graeme J Hankey, John W Eikelboom
Mar 19, 2004·Journal of the American College of Cardiology·Deepak L Bhatt
Feb 11, 2005·Journal of Thrombosis and Haemostasis : JTH·C L Campbell, S R Steinhubl
Mar 2, 2005·Annals of Internal Medicine·Simon SandersonAnn-Louise Kinmonth
Feb 21, 2006·Lancet·Graeme J Hankey, John W Eikelboom
Jan 19, 2008·BMJ : British Medical Journal·George KrasopoulosMichael R Buchanan
Nov 13, 2008·Pediatric Blood & Cancer·Torrey M ParkerRobert J Klaassen
Feb 23, 2010·Expert Review of Hematology·Stefano Rivella, Eliezer Rachmilewitz
Feb 11, 2012·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Sezaneh Haghpanah, Mehran Karimi
Jun 5, 2013·Haematologica·Khaled M MusallamEliezer A Rachmilewitz

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Rahajuningsih SetiabudyLyana Setiawan
Nihon rinsho. Japanese journal of clinical medicine
Y Mito
Nihon rinsho. Japanese journal of clinical medicine
M Miura, F Kurimoto
Surgery, Gynecology & Obstetrics
F A ARCARI, H B LYNN
© 2021 Meta ULC. All rights reserved